It’s a savings offer that can provide commercially insured, eligible patients up to $300* in out-of-pocket savings for each EPIPEN 2-PAK^® 
and/or EPIPEN JR 2-PAK^® carton—up to three cartons (six Auto-Injectors) per prescription fill, so patients have immediate access to an
EPIPEN 2-PAK and/or EPIPEN JR 2-PAK cartons in multiple locations.

Patients can find out if they’re eligible here

It's a savings offer that can provide commercially insured, eligible patients up to $25* in out-of-pocket savings for each two-pack carton of the Epinephrine Injection, USP Auto-Injector (The authorized generic to EPIPEN)—up to three cartons (six Auto-Injectors) per prescription fill, so patients have immediate access to a two-pack in multiple locations.

Patients can find out if they’re eligible here

*Certain restrictions apply. See full Terms and Conditions for the EPIPEN Savings Card here and the Epinephrine Injection, USP Auto-Injector Card Savings card here. These savings offers are not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Mylan Specialty L.P., a Viatris Company reserves the right to amend or end this program at any time without notice.

Viatris has enhanced its Patient Assistance Program to help increase access to EPIPEN. To enroll, patients must complete the Patient Assistance Program form with their physician. Patients can obtain additional information on the program by emailing customer.service@Viatris.com or calling Viatris Customer Relations at 1-800-796-9526 to speak with a representative.

To participate in the program, patients must meet the eligibility criteria set forth below:

• The patient must be a US citizen or a legal resident living in the United States.
• The patient's gross yearly household income must fall below 400% of the current federal poverty guidelines, based upon family size. Verification documents will be required.

  Approved Documents: 1040, 1040EZ, W2, 4506-T, SSI Statement, Disability Statement, or Statement From Physician, Nurse, or Patient Advocate, or Certified Notarized Statement From the Applicant

• The patient must meet one of the following conditions:
  • The patient must not have prescription insurance coverage through Medicaid, Medicare Part D, TriCare, a qualified health plan purchased on a state-based, partnership, or federally facilitated exchange, or any other public or private program or insurer. Verification documents will be required.
    Approved Documents: Denial Letter, Termination Statement, Statement From Physician, Nurse, or Patient Advocate, or Certified Notarized Statement From the Applicant.
  • The patient has commercial prescription drug coverage only for generic products and the patient must not have prescription insurance coverage through any state or federally funded program, including, without limitation, Medicare, Medicaid, TriCare or Medicare Part D. Verification documents will be required.
    Approved Documents: Denial Letter, Termination Statement, Statement From Physician or Nurse, or Verification of Applicant's Coverage From the Insurer.
  Download Form

With the EPIPEN4SCHOOLS program, Mylan Specialty L.P., a Viatris Company offers four free EPIPEN (epinephrine injection, USP) or EPIPEN JR^® (epinephrine injection, USP) Auto-Injectors in the form of two EPIPEN 2-PAK cartons, two EPIPEN JR 2-PAK cartons or one 2-Pak of each kind, upon qualification, which includes having a valid prescription, to public and private kindergarten, elementary, middle and high schools in the US. Schools may receive the authorized generic versions of EPIPEN and EPIPEN JR.

To participate in EPIPEN4SCHOOLS, a school nurse or other authorized school representative must visit WWW.EPIPEN4SCHOOLS.COM to download the order and certification form, and then fax or email the form with a valid prescription to 1-973-718-4328 or info@bioridgepharma.com Alternatively, school representatives can call 1-973-845-7600 to speak with a live representative. There is no requirement for a school to purchase additional EPIPEN Auto-Injectors or any other Viatris Inc. products.